Dr. Josh David Simmons, MD

Dr. Simmons practices at Archbold Memorial in Thomasville, Georgia, part of Archbold.

Dr. Simmons' NPI, 1942461132, was assigned on June 19, 2008. Dr. Simmons graduated from American University of the Caribbean School of Medicine in 2008. Dr. Simmons holds Georgia license 064969.

Dr. Simmons' primary practice is Archbold Memorial, at 915 Gordon Avenue & Mimosa Drive, Thomasville, GA 31792 in Thomas County. The practice phone is (229) 228-2880.

Dr. Simmons' primary practice is Archbold Memorial in Thomasville, Georgia, part of Archbold. Dr. Simmons is also affiliated with Archbold Grady. The medical group on file is Archbold Medical Group. Dmand AI also links Dr. Simmons to 2 more hospitals, 2 group practices and clinics, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Simmons practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Simmons' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Simmons is licensed in Georgia.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma and multiple myeloma among the conditions Dr. Simmons treats.

CMS data shows 726 Medicare services from Dr. Simmons across 6 procedure codes in 2024, for 228 Medicare patients. Medicare paid $62,164 for them.

CMS counts 228 Medicare patients who saw Dr. Simmons in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Simmons' median patient age at 73, with 57% women.

In 2024, Dr. Simmons wrote 978 Medicare Part D claims for 173 patients. 66% of them were for generic drugs. CMS names the drug for 720 of them, across 26 drugs with 11 or more claims each, at $3,582,635 in total drug cost. In 2023, CMS named 654 claims across 28 drugs.

Dr. Simmons accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Simmons, published from 2019 to 2025. 2025 was the busiest year, with 2. Dr. Simmons' most frequent co-authors are Ji Y. Chong, MD, David Michael Ellison, MD and Chirag D. Gandhi, MD.

Dmand AI links Dr. Simmons to 10 clinical trials, 4 of them phase 2 studies. 7 are still active or recruiting. Conditions studied include Carcinoma, Bronchogenic, Breast Neoplasms and Carcinoma, Non-Small-Cell Lung. National Cancer Institute (NCI) sponsors the most, 6.

CMS Open Payments shows 208 general payments to Dr. Simmons from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Amgen Inc. paid the most, $485. It also lists 5 research payments totaling $2,818 from 2023 to 2024.

Dmand AI lists 1 award for Dr. Simmons, most recently Physician of the year in 2019.

Dr. Simmons graduated from American University of the Caribbean School of Medicine in 2008.

Dr. Simmons is in network with 15 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.